Document is current

Article History

Received: 22 March 2021

Accepted: 17 March 2022

First Online: 9 April 2022

Declarations

:

: According to the National Scientific Ethical Committees Act § 1, subparagraph 2, the study did not require ethical approval. The study was approved by the Danish Data Protection Agency (AHH-2016-080, I-Suite no.: 05078) and followed the ethical principles of the Helsinki Declaration (Code N, 1949). Participants in the feasibility study were informed that participation was voluntary and that withdrawal was possible at any time without loss of their right to treatment. Informed written consent was obtained from all patients included in the feasibility study after provision of both oral and written information. Full anonymity was ascertained by allocating an ID number to each participant instead of using their names. In the fidelity study field notes, observed health care professionals were assigned a code instead of using their full names. Before conducting the observations, all staff were informed about the aim of the study and were assured that participation was voluntary. Since our presence as observers of the daily practice was approved by the head and ward managers, written informed consent was not obtained from each health care professional before the study. However, each health care professional had the possibility of declining to be followed in their daily work or to answer clarifying questions. However, none of the staff chose to do so. During observation, we tried to take situational ethics into account by considering the context’s specific circumstances, e.g., ensuring that we respected the patients’ privacy and the health care professionals’ need for room for actions [].

: Not applicable.

: The authors declare that they have no competing interests.